• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[以癌症筛查为例,权衡基于人群的干预措施的利弊]

[Balancing benefits and harms of population-based interventions, using the example of cancer screening].

作者信息

Gartlehner Gerald

机构信息

Department für Evidenzbasierte Medizin und Klinische Epidemiologie, Donau Universität Krems Österreich.

出版信息

Z Evid Fortbild Qual Gesundhwes. 2011;105(3):176-82. doi: 10.1016/j.zefq.2011.03.004. Epub 2011 Mar 26.

DOI:10.1016/j.zefq.2011.03.004
PMID:21530906
Abstract

The assessment of the balance between benefits and harms of population-based interventions faces both methodological and practical difficulties. This paper uses the example of cancer screening to outline existing challenges such as the consideration of outcomes that occur at substantially different times, or the lack of direct evidence which can lead to false conclusions and adverse health effects for healthy individuals undergoing screening. Sometimes not even sound evidence provides clear answers about the benefits and harms of preventive interventions. This is why informed decision-making is a particularly important step for individuals taking preventive interventions into consideration. Due to the lack of a clear answer to the question of benefits and harms from scientific evidence, individuals' attitudes and values may become a decisive factor. Studies, however, indicate that the prerequisite for informed decision making, namely objective and balanced information about benefits and harms, is often missing.

摘要

基于人群的干预措施利弊平衡评估面临方法学和实践方面的困难。本文以癌症筛查为例,概述了现有挑战,如考虑在截然不同时间发生的结果,或缺乏直接证据,这可能导致对接受筛查的健康个体得出错误结论并产生不良健康影响。有时,即使是可靠的证据也无法就预防性干预措施的利弊提供明确答案。这就是为什么明智决策对于考虑采取预防性干预措施的个人来说是特别重要的一步。由于科学证据未能明确回答利弊问题,个人的态度和价值观可能成为决定性因素。然而,研究表明,明智决策的先决条件,即关于利弊的客观和平衡信息,往往缺失。

相似文献

1
[Balancing benefits and harms of population-based interventions, using the example of cancer screening].[以癌症筛查为例,权衡基于人群的干预措施的利弊]
Z Evid Fortbild Qual Gesundhwes. 2011;105(3):176-82. doi: 10.1016/j.zefq.2011.03.004. Epub 2011 Mar 26.
2
American Cancer Society guideline for the early detection of prostate cancer: update 2010.美国癌症协会前列腺癌早期检测指南:2010 年更新版。
CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3.
3
A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.低风险至高风险男性前列腺特异性抗原筛查结果模型:支持明智选择的信息
Arch Intern Med. 2009 Sep 28;169(17):1603-10. doi: 10.1001/archinternmed.2009.282.
4
Prostate cancer and prostate-specific antigen (PSA) screening in Austria.奥地利的前列腺癌与前列腺特异性抗原(PSA)筛查
Wien Klin Wochenschr. 2005 Jul;117(13-14):457-61. doi: 10.1007/s00508-005-0395-y.
5
Balancing the harms and benefits of early detection of prostate cancer.权衡前列腺癌早期检测的危害和益处。
Cancer. 2010 Oct 15;116(20):4857-65. doi: 10.1002/cncr.25474.
6
Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.前列腺癌的早期诊断:关于其对死亡率影响的持续争论。
Wien Klin Wochenschr. 2005 Jul;117(13-14):440-1. doi: 10.1007/s00508-005-0398-8.
7
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?使用前列腺特异性抗原检测筛查前列腺癌:患者是否在做出明智的决策?
J Fam Pract. 1999 Sep;48(9):682-8.
8
Should prostate-specific antigen screening be offered to asymptomatic men?是否应向无症状男性提供前列腺特异性抗原筛查?
Expert Rev Anticancer Ther. 2010 Jul;10(7):1043-53. doi: 10.1586/era.10.64.
9
The Japanese guideline for prostate cancer screening.日本前列腺癌筛查指南。
Jpn J Clin Oncol. 2009 Jun;39(6):339-51. doi: 10.1093/jjco/hyp025. Epub 2009 Apr 4.
10
Communicating benefits and risks of screening for prostate, colon, and breast cancer.传达前列腺癌、结肠癌和乳腺癌筛查的益处与风险。
Fam Med. 2011 Apr;43(4):248-53.